Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In Your Second Chance For Patients with Pulmonary Arterial Hypertension with NYHA Class III or IV Symptoms
Ventavis Patient Stories
I-neb AAD Learning Center
PAH Learning Center
PAH Pathways - Actelion Services & Support

Contact Us

Actelion Pharmaceuticals US, Inc.
5000 Shoreline Court, Suite 200
South San Francisco, CA 94080
1.866.228.3546 Phone
415.268.9515 Fax

Medical Information

For further medical information on Ventavis or PAH, please contact our Medical Information Department by calling 1.866.228.3546 or by sending a fax to 415.268.9515. Contact us via e-mail at: usmedinfo@actelion.com.

The hours of operation for the Medical Information Department are 9:00 a.m. to 5:00 p.m. PST, Monday through Friday excluding holidays.

For information on ongoing patient support and education, contact Sure Steps™ at 1-877-STEPS-50 (1-877-783-7750)—Monday through Friday, between 8 a.m. and 11 p.m. Eastern Time.



IMPORTANT SAFETY INFORMATION:
Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.

I-neb AAD is a registered trademark of Philips Respironics.

Please see full Prescribing Information

For more information about
Ventavis, please call
1-866-ACTELION (1-866-228-3546).

Policies & Disclaimers  |  Contact Us   |  Site Map  |  Important Safety Information

THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.
SECOND WIND is a licensed trademark of Pulmonary Rehabilitation Associates.
©2010 Actelion Pharmaceuticals US, Inc. All rights reserved.

ACTELION